reports
MYR Group Inc. Announces New $75 Million Share Repurchase Program
MYR Group Inc. Announces New $75 Million Share Repurchase Program THORNTON, Colo., May 06, 2024 (GLOBE NEWSWIRE) -- MYR Group Inc. (“MYR Group” or the “Company”) (NASDAQ: MYRG), a holding company of leading specialty contractors serving the electric utility infrastructure, commercial and industrial construction markets in the United States and Canada, announced today a new share repurchase program (“Repurchase Program”). The Repurchase Program authorizes the Company to repurchase, in the aggregate, up to $75.0 million of its outstanding shares of common stock from time to time on the open...
Vimeo Q1 2024 Shareholder Letter Available on Company's IR Site
Vimeo Q1 2024 Shareholder Letter Available on Company's IR Site NEW YORK, May 06, 2024 (GLOBE NEWSWIRE) -- Vimeo posted its first quarter 2024 shareholder letter on the investor relations section of its website at . About VimeoVimeo (NASDAQ: VMEO) is the world's most innovative video experience platform. We enable anyone to create high-quality video experiences to better connect and bring ideas to life. We proudly serve our community of millions of users – from creative storytellers to globally distributed teams at the world's largest companies – whose videos receive billions of views ...
Global-e to Announce Financial Results for the First Quarter 2024 on M...
Global-e to Announce Financial Results for the First Quarter 2024 on May 20, 2024 PETAH-TIKVA, Israel, May 06, 2024 (GLOBE NEWSWIRE) -- Global-e Online Ltd. (Nasdaq: GLBE) the leader of global Direct-To-Consumer ecommerce enablement, today announced it will report financial results for the first quarter ended March 31, 2024, before market open on Monday, May 20, 2024. Global-e management will host a conference call to review its financial results and outlook. Date:Monday, May 20, 2024Time:8:00 a.m. ETUnited States/Canada Toll Free:1-888-886-7786International Toll: Please join the call...
Adeia Announces First Quarter 2024 Financial Results
Adeia Announces First Quarter 2024 Financial Results Paid down $40 million of debt in the first quarter and nearly $200 million since separation Generated over $67 million in cash from operations in the first quarter SAN JOSE, Calif., May 06, 2024 (GLOBE NEWSWIRE) -- Adeia Inc. (Nasdaq: ADEA) (the “Company” or “Adeia”) today announced financial results for the first quarter ended March 31, 2024. “The results of our first quarter demonstrate the strength of our business model and continued execution as we generated over $67 million in cash from operations,” said Paul E. Davis, chief e...
ThredUp Announces First Quarter 2024 Results
ThredUp Announces First Quarter 2024 Results First quarter revenue of $79.6 million, representing an increase of 5% year-over-year.First quarter gross margin of 69.5% and an increase in gross profit of 8% year-over-year.Active Buyers of 1.7 million and Orders of 1.7 million in Q1 2024, representing an increase of 4% and an increase of 9%, respectively, year-over-year.Issued an updated 2024 financial outlook, including positive adjusted EBITDA margin in the range of 2.0% to 4.0% and positive free cash flow on an annual basis. OAKLAND, Calif., May 06, 2024 (GLOBE NEWSWIRE) -- ThredUp Inc. ...
Saratoga Investment Corp. Announces Fiscal Year-End and Fourth Quarter...
Saratoga Investment Corp. Announces Fiscal Year-End and Fourth Quarter 2024 Financial Results NEW YORK, May 06, 2024 (GLOBE NEWSWIRE) -- Saratoga Investment Corp. (NYSE:SAR) (“Saratoga Investment” or “the Company”), a business development company (“BDC”), today announced financial results for its 2024 fiscal year and fourth quarter, with Net Investment Income (“NII”) per share up 53% from last year and up 16% over last year’s fourth quarter, and adjusted NII per share up 44% from last year and down 4% from last year’s fourth quarter. The substantial year-over-year increase in NII reflects...
Alto Ingredients, Inc. Reports First Quarter 2024 Results
Alto Ingredients, Inc. Reports First Quarter 2024 Results – Improved Q1 2024 Gross Profit by $0.8 Million, Net Loss by $1.4 Million and Adjusted EBITDA by $3.4 Million over Q1 2023 – PEKIN, Ill., May 06, 2024 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO), a producer and distributor of renewable fuel and essential ingredients and the largest producer of specialty alcohols in the U.S., reported its financial results for the quarter ended March 31, 2024. For the first quarter of 2024, gross loss improved by $0.8 million, net loss improved by $1.4 million and Adjusted EBITDA imp...
Sana Biotechnology to Present at May and June 2024 Investor Conference...
Sana Biotechnology to Present at May and June 2024 Investor Conferences SEATTLE, May 06, 2024 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentations at three investor conferences in May and June. The presentations will feature a business overview and update. Sana will present at the Citizens JMP Securities Life Sciences Conference at 11:30 a.m. ET on Monday, May 13, 2024.Sana will present at the BofA Securities 2024 Healthcare Conference at 3:...
EverQuote Announces First Quarter 2024 Financial Results
EverQuote Announces First Quarter 2024 Financial Results First Quarter Revenue of $91.1 millionFirst Quarter Variable Marketing Margin of $30.8 millionFirst Quarter Record GAAP Net Income of $1.9 million and Adjusted EBITDA of $7.6 million CAMBRIDGE, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- EverQuote, Inc. (Nasdaq: EVER), a leading online insurance marketplace, today announced financial results for the first quarter ended March 31, 2024. “We had a strong start to 2024, delivering first quarter results that exceeded the high end of our guidance range for revenue, Variable Marketing Margin...
ORIC Pharmaceuticals Reports First Quarter 2024 Financial Results and ...
ORIC Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Updates Initiated three ORIC-114 Phase 1b expansion cohorts in NSCLC patients with EGFR exon 20 insertion, HER2 exon 20 insertion, or EGFR atypical mutations; updated Phase 1b data expected in the first half of 2025 Presented initial ORIC-944 Phase 1b monotherapy data demonstrating potential best-in-class profile with strong pharmacokinetic, pharmacodynamic, and safety results in patients with prostate cancer; proceeding into combination with AR inhibitor(s) in metastatic prostate cancer Presented updated O...
Shockwave Medical Reports First Quarter 2024 Financial Results
Shockwave Medical Reports First Quarter 2024 Financial Results SANTA CLARA, Calif., May 06, 2024 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of cardiovascular disease, today reported financial results for the three months ended March 31, 2024. “The solid growth in the first quarter across geographies and products is a testament to the continued demand for our innovative solutions, driven by the unrelenting and extraordinary performance of our global Shockwave teams,” said...
Matterport Announces First Quarter 2024 Financial Results
Matterport Announces First Quarter 2024 Financial Results Annualized Recurring Revenue hits record $96 million, up 21% year-over-yearNet loss improved 33% year-over-year; Non-GAAP net loss improved 80% year-over-yearCash used in operating activities improved 81% year-over-yearNet Dollar Expansion rate of 107% Total subscribers reach 1.0 million, up 30% year-over-yearSquare feet under management reached 40.7 billion, up 35% from prior year SUNNYVALE, Calif., May 06, 2024 (GLOBE NEWSWIRE) -- Matterport, Inc. (Nasdaq: MTTR) (“Matterport” or the “Company”), the leading spatial data company ...
Varonis Announces First Quarter 2024 Financial Results
Varonis Announces First Quarter 2024 Financial Results Annual recurring revenues grew 17% year-over-yearSaaS ARR as a percentage of total ARR was approximately 30%Year-to-date cash from operations generated $56.7 million vs. $36.8 million last yearYear-to-date free cash flow generated $56.4 million vs. $35.7 million last year NEW YORK, May 06, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: VRNS), a leader in data security, today announced financial results for the first quarter ended March 31, 2024. Yaki Faitelson, Varonis CEO, said, "Our first quarter results reflect the continued strong a...
Telesis Bio Announces Reverse Stock Split
Telesis Bio Announces Reverse Stock Split SAN DIEGO, May 06, 2024 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (the Company) (NASDAQ: TBIO), a leading provider of RNA and DNA solutions enabling researchers to accelerate therapeutic discovery through advanced, flexible, and rapid automated synthesis in their own lab, today announced that it will effect a 1-for-18 reverse stock split of its common stock. The reverse stock split will take effect at 12:01 am (Eastern Time) on Thursday, May 9, 2024, and the Company's common stock will open for trading on The Nasdaq Global Select Market on May 9, 2024 ...
Pliant Therapeutics Provides Corporate Update and Reports First Quarte...
Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results BEACON-IPF pivotal, adaptive Phase 2b/3 trial design implementation significantly accelerates bexotegrast development in IPF Data from completed 12 week Phase 2a imaging trial measuring bexotegrast’s effect on total lung collagen and FVC in IPF patients expected in the coming weeksRegulatory clearance for muscular dystrophy program PLN-101325 received, allowing conduct of a first-in-human Phase 1 clinical study SOUTH SAN FRANCISCO, Calif., May 06, 2024 (GLOBE NEWSWIRE) -- Pliant Therapeutics...
Regeneron Announces Investor Conference Presentations
Regeneron Announces Investor Conference Presentations TARRYTOWN, N.Y., May 06, 2024 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management participation as follows: RBC Capital Markets Global Healthcare Conference at 9:00 a.m. ET on Tuesday, May 14, 2024Jefferies Global Healthcare Conference at 8:30 a.m. ET on Wednesday, June 5, 2024Goldman Sachs 45th Annual Global Healthcare Conference at 8:00 a.m. ET on Tuesday, June 11, 2024 The sessions may be accessed from the "Investors & Media" page of Regeneron's website at . Replays and transcripts of the web...
LAVA Therapeutics to Participate in the Citizens JMP Life Sciences Con...
LAVA Therapeutics to Participate in the Citizens JMP Life Sciences Conference UTRECHT, The Netherlands and PHILADELPHIA, May 06, 2024 (GLOBE NEWSWIRE) -- LAVA Therapeutics N.V. (NASDAQ: LVTX, “LAVA,” or “Company”), a clinical-stage immuno-oncology company focused on developing its proprietary Gammabody® platform of bispecific gamma-delta (δ2) T cell engagers, today announced that Stephen Hurly, President and Chief Executive Officer of LAVA Therapeutics, will participate in a fireside chat at the Citizens JMP Life Sciences Conference. Presentation Details Format: Fireside ChatDate: Monda...
Ohmyhome Announces Receipt of Nasdaq Notification Letter Regarding Min...
Ohmyhome Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency Singapore, May 06, 2024 (GLOBE NEWSWIRE) -- Ohmyhome Ltd. (NASDAQ: OMH , “ Ohmyhome ”, “the Company”), a one-stop-shop property technology platform providing end-to-end property solutions and services including brokerage, renovation and condominium property management services in Singapore, today announces that it has received a deficiency letter from the Listing Qualifications Department (the “Staff”) of The Nasdaq Capital Market (“Nasdaq”) on April 30, 2024, notifying the Company that it was ...
Exagen Announces Campaign for Lupus Awareness Month
Exagen Announces Campaign for Lupus Awareness Month CARLSBAD, Calif., May 06, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced, in recognition of Lupus Awareness Month, the launch of a campaign focusing on providers, patients and partnership activities that enhance the impactful work being done to help those suffering from Systemic Lupus Erythematosus (SLE). Lupus Awareness Month occurs every May and is an important platform for lupus-focused organizations to educate and advocate for those affected by this complex con...
United States Lime & Minerals Announces 5-for-1 Stock Split
United States Lime & Minerals Announces 5-for-1 Stock Split DALLAS, May 06, 2024 (GLOBE NEWSWIRE) -- United States Lime & Minerals, Inc. (NASDAQ: USLM) (the “Company”) today announced that it will conduct a split of its outstanding shares of common stock at a ratio of 5:1, effected in the form of a stock dividend of four additional shares of common stock for each share outstanding. The Company’s Board of Directors determined that, with the significant growth of the trading price for the Company’s common stock over the past several years, the stock split is appropriate to make the Company’...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.